Dr. Nancy Speck shares her research findings around the regulatory role of RUNX1 in inflammation, specifically how loss of RUNX1 results in epigenetic reprogramming that reduces control of TLR4 and type I IFN signaling pathways, leading to an increase in retrotransposons activity.